Perfil
Dr. Richard Philipson, MD, is a Chief Medical Officer at Hansa Biopharma AB and a Member at The Royal College of Physicians.
Dr. Philipson was previously employed as a Chief Medical Officer by Calliditas Therapeutics AB and a Chief Medical Officer by Trizell Ltd. He received his undergraduate degree from the University of London.
Cargos activos de Richard Philipson
| Empresas | Cargo | Inicio |
|---|---|---|
| HANSA BIOPHARMA AB | Director Técnico/Científico/I+D | 14/07/2025 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Richard Philipson.
| Empresas | Cargo | Fin |
|---|---|---|
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Director Técnico/Científico/I+D | 01/07/2020 |
| CALLIDITAS THERAPEUTICS AB | Director Técnico/Científico/I+D | - |
Formación de Richard Philipson.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Trizell Ltd.
Trizell Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
- Bolsa de valores
- Insiders
- Richard Philipson
















